Union Commerce Minister engages pharma stakeholders to address exporter challenges
During the meeting, the focus was laid on identifying key hurdles that pharmaceutical exporters encounter.
Written By : Farhat Nasim
Published On 2024-10-18 04:00 GMT | Update On 2024-10-18 04:00 GMT
New Delhi: Union Commerce and Industry Minister Piyush Goyal recently convened an important meeting with key stakeholders from the pharmaceutical sector to discuss and address the concerns of pharmaceutical exporters.
The meeting held on Wednesday was attended by the General Secretary of the Indian Drug Manufacturers Association (IMDA), along with several other prominent stakeholders from the pharmaceutical industry.
According to a statement by minister's office, the discussions aimed to address the pressing challenges faced by pharmaceutical exporters and explore potential solutions to enhance India's global standing in the sector.
"Minister@PiyushGoyalheld a meeting with Mr. Mehul Shah, General Secretary of the Indian Drug Manufacturers Association (IMDA) and other pharma industry stakeholders. Discussions centred on addressing the challenges faced by pharma exporters and exploring potential solutions to further strengthen India's position in pharmaceutical sector globally" said minister's office in a post on X on Wednesday.
During the meeting, the focus was laid on identifying key hurdles that pharmaceutical exporters encounter.
With the Indian pharmaceutical industry being one of the largest in the world, accounting for a significant share of global generic drug supply, overcoming these challenges is seen as critical to ensuring sustained growth and competitiveness.
The discussions also emphasized the need for continued collaboration between the government and the industry to ensure that Indian pharmaceutical products remain competitive in terms of both quality and pricing.
In addition to addressing immediate concerns, the discussions also touched upon the long-term vision of further solidifying India's reputation as a leading pharmaceutical hub.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.